Waiver attestations for Electronic Health Records (EHR)/Prescription Monitoring Program (PMP) integration must be submitted annually, by December 1 of each year for the proximate year. For example, for calendar year 2025, providers should resubmit a waiver attestation by December 1, 2024. All health care facilities with ten or more prescribers, excluding critical access hospitals, must have fully integrated their EHR systems with the state’s PMP or have obtained a waiver from the Department of Health (DOH).  

To qualify for a waiver, an organization must be experiencing an economic hardship, technological limitations, or other exceptional circumstance. Most WSDA members qualify for the waiver under the exceptional circumstances category as they generate fewer than one hundred prescriptions of Schedule II – Schedule V drugs in a one-year period (both new and refill authorizations).

Submit a Waiver

E-Prescribing Waiver Attestation

Similar to the EHR/PMP integration waiver attestation, waiver attestations for e-prescribing must be submitted annually, by December 1 of each year for the proximate year. For example, for calendar year 2025, providers should resubmit a waiver attestation by December 1, 2024. All information concerning a prescription for controlled substances Schedule II — Schedule V, or information concerning a refill authorization for controlled substances Schedule III — Schedule V, must be communicated electronically unless one of the authorized exemptions are met, or the health care provider has obtained a waiver from the DOH.

To qualify for an e-prescribing waiver from the DOH, the provider must be experiencing an economic hardship, technological limitations, or other exceptional circumstance. Most WSDA members qualify for the waiver under the exceptional circumstances category as they generate fewer than one hundred prescriptions of Schedule II – Schedule V drugs in a one-year period (both new and refill authorizations).